Syneron Medical Ltd. and its North American subsidiary Syneron Inc., today announced that Syneron has received US Food & Drug Administration (FDA) clearance to market the Aurora DS(TM) system for non-invasive hair removal. Aurora DS received its CE mark in December of 2001 and is already cleared for sales in Europe, Canada, and other parts of the world. The system has already established a strong acceptance rate among physicians and patients outside of the US.

The Aurora DS utilizes Syneron's proprietary ELOS(TM) (Electro-Optic Synergy System) technology to combine optical energy and electrical energy (conducted RF). It provides the basis for highly efficient, safe and cost-effective systems that e n able physicians to offer new and improved services to their patients.

The FDA clearance of Aurora DS for hair removal is supported by data generated in a multi-site, prospective clinical study that was carried out by a group of highly distinguished medical investigators in the U.S. and Canada, including:

Dr. Jerome M. Garden, Northwestern University, Chicago, Illinois
Dr. Suzanne Kilmer, Sacramento, California
Dr. George Hruza, St. Louis, Missouri
Dr. Sharyn Laughlin, Laserderm, Ottawa, Ontario, Canada
Dr. Fred Weksberg, Toronto, Ontario, Canada

"The combination of both radio-frequency and optical energy in the Syneron system, known as ELOS technology, is an innovative and exciting development in the treatment of ha ir rem oval," commented Dr. Jerome Garden. "With this approach, one may achieve hair reduction while minimizing the applied light energy and its associated undesired side effects. There is the potential to more safely treat a broader range of hair and skin colors. This technology should also have application for other skin processes that have previously benefited from laser and pulsed light systems.

Added Domenic Serafino, President-North America of Syneron Inc.: "We are very excited to offer today's most advanced technology for the quick, gentle, safe, and effective removal of unwanted body hair. The clinical study and experience from the field proves that our unique ELOS technology is superior to any light-based technology for the long-term removal of all hair and skin types, including blond, red, and gr ay hai r . Prior to ELOS technology, photon-based hair removal systems only targeted the melanin within the hair shaft in order to damage the follicle. ELOS technology targets the entire follicle as its primary target, which provides superior results."

About Aurora DS
The Aurora DS hair removal system is designed to provide maximum safety and efficacy in removing unwanted hair from all parts of the body regardless of skin or hair type, with minimal patient discomfort. Based on Syneron's proprietary ELOS (Electro-Optical Synergy) technology, Aurora DS utilizes a unique combination of light energy, conducted RF and cooling, enabling highly selective targeting of the follicle and shaft. Effective cooling and skin impedance monitoring enables fully controllable treatment.

About Syneron
Syneron is dedicated to maximizing the synergy between electrical energy and optical energy to provide advanced solut io ns fo r a broad range of medical-aesthetic applications. The Company's innovative patent-pending ELOS technology provides the foundation for highly efficient, safe, and cost-effective systems that enable physicians and medical professionals to offer new and improved services to their patients. Founded in 2000, Syneron's R&D headquarters, Syneron Medical Ltd., is located in Israel. Its sales, service and support subsidiary, Syneron Inc., is located in Toronto, Canada. Please visit http://www.syneron.com.

For more information, please contact Domenic Serafino, President-North America, at Tel. (866) 259-6661 ext. 247, email: doms@syneron.com.

Syneron Medical Ltd.Soltam Technology ParkP.O.B. 550Yokneam Illit, 20692IsraelTel: +972 4 909-7424Fax: +972 4 909-7417info@syneron-med.com
Syneron Inc.100 West Beaver Creek Rd. Unit 6Richmond Hill, Ontario, CanadaL4B 1H2Tel: (1) 905-886-9235 Fax: (1) 905-886-7046 Toll Free: 1-866-259-6661
gordp@syneron-med.com

Syneron, the Syneron logo, Aurora, and the Aurora logo are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. ELOS (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

www.syneron.com resolves to 192.197.109.64
www.syneron-med.com resolves to 192.116.93.40

R.F.L. Technologies LTD
Michael Kreindel
Bar Rav Hai David 33
Haifa, 35592, IL
Phone: 97248339177
Fax..: 9726101189
Email: mkreindel@yahoo.com

de toestemming van de EC. Voor Nederland: passend in het Besluit Medische Hulpmiddelen

DECLARATION OF CONFORMITY MEDICAL DEVICES

We hereby declare that the distributed CE marked products, specified in the annexed product list, are covered by the "CE Marking of Conformity Certificate", reference number: 2013886CE01, issued on 2001 and delivered by N.V.-KEMA, Arnhem, The Netherlands, Notified Body Identification Number 0344, and conform to the required technical documentation, in accordance with Annex VII of the law `Besluit Medische Hulpmiddelen' of The Netherlands transposing the "EC-Directive", the Council Directive 93/42/EEC of 14 June 1993, concerning medical devices.

In addition, we ensure and declare that the distributed CE marked products, as mentioned and falling within Class IIA, meet the provisions of the ED-Directive which apply to them.

This declaration is based on the application of the Quality System approved for the manufacture and final inspection of the products concerned, in accordance with Annex V of the EC-Directive. The conformity of the production quality assurance set out in Annex V, is described in the said CE Marking of Conformity Certificate, issued and delivered by N.V. Kema.

This declaration is supported by the Quality System certification based on the harmonized standards ISO 9001/ EN 46001, Quality System Certificate with reference number: 23420, issued on 21.08.2001 and delivered by the "Standards Institution of Israel".

This Declaration of Conformity covers Aurora as specified in the productlist belonging to this declaration, and is valid for all products concerned bearing the CE marking and manufactured at the following site(s):